| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 06/20/2002 | US20020077455 Protease inhibitors |
| 06/20/2002 | DE10063008A1 Carbonsäureamidderivate Carboxamide |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | CA2432825A1 Nonpeptide agonists and antagonists of vasopressin receptors |
| 06/20/2002 | CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/19/2002 | EP1214295A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/19/2002 | EP1214293A1 Non-peptidic cyclophilin binding compounds and their use |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/18/2002 | US6407120 Administering pyridinylacetamide or phenylacetamide derivative to treat cardiovascular, eating, sexual, brain, nervous system, gastrointestinal, urogenital, psychological, and respiratory system disorders |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046148A1 Substituted anthranilic acids |
| 06/13/2002 | WO2002046147A2 Perturbed membrane-binding compounds |
| 06/13/2002 | WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046129A2 Inhibitors of histone deacetylase |
| 06/13/2002 | WO2002028825A3 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 06/13/2002 | WO1999059957A9 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
| 06/13/2002 | US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders |
| 06/13/2002 | US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 06/13/2002 | US20020072514 For use in prophylaxis and therapy of cardiovascular disorders, in particular arrhythmias, for treatment of prophylaxis and therapy of cardiovascular disorders, in particular arrhythmias, for therapy of diarrheal disorders |
| 06/13/2002 | US20020072513 Process for the production of clavulanic acid salts |
| 06/13/2002 | CA2436870A1 Substituted anthranilic acids |
| 06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2436601A1 Perturbed membrane-binding compounds |
| 06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP0966437B1 5-aroylnaphthalene derivatives |
| 06/12/2002 | EP0873312B1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/12/2002 | CN1353692A Betz 2-adrenoceptor agonists |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353684A Ether compounds, compositions, and uses thereof |
| 06/11/2002 | US6403644 For prevention and/or treatment of diseases induced by overexpression and excess activity of matrix metalloproteinase; for example, rheumatoid, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis |
| 06/11/2002 | US6403607 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 06/11/2002 | US6403600 Fungicides. |
| 06/06/2002 | WO2002044139A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/06/2002 | WO2002044126A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 06/06/2002 | WO2002044111A1 Transfer hydrogenation process and catalyst |
| 06/06/2002 | WO2002020474A3 Resorcinol derivatives |
| 06/06/2002 | WO2002004406A3 9-substituted minocycline compounds |
| 06/06/2002 | US20020068687 Methods and compositions for inhibiting cell proliferative disorders |
| 06/06/2002 | US20020067472 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action |
| 06/06/2002 | CA2430409A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use |
| 06/06/2002 | CA2430295A1 Transfer hydrogenation process and catalyst |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1003719B1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives |
| 06/05/2002 | EP0968178B1 N-sulphonyl and n-sulphinyl amino acid amides as microbicides |
| 06/05/2002 | EP0966430B1 Anti-inflammatory compounds |
| 06/05/2002 | EP0923539B1 Compounds with growth hormone releasing properties |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | US6399824 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure |
| 06/04/2002 | US6399821 Reacting a sulphonyl halide with nucleophilic base |
| 06/04/2002 | US6399820 Process and reagent useful for the synthesis of sulphanilide which is perhalogenated on the carbon borne by the sulphur atom of the sulphanilide function |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2001023352A8 Preparation of sulfonyl imine compounds |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/30/2002 | US20020065196 As color-developing agent; high whiteness and resistance to color formation under high temperature |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/29/2002 | EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/28/2002 | US6395930 Quenching reagents for solution phase synthesis |
| 05/28/2002 | US6395919 Calcilytic compounds |
| 05/28/2002 | US6395897 Drugs for enzyme inhibitors anticoagulants and treatment of autoimmune disease |
| 05/28/2002 | US6395737 Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them |
| 05/28/2002 | US6395735 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor |
| 05/28/2002 | US6395367 Electroconductivity |
| 05/23/2002 | WO2002040491A1 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catayltic reactions |
| 05/23/2002 | WO2002040446A1 Glucagon antagonist/inverse agonist |
| 05/23/2002 | WO2002040444A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | WO2001094306A3 (bis)sulfonamide derivatives |
| 05/23/2002 | US20020062029 Suitable for the preparation of herbicidal active substances such as sulfonylureas. |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | US20020061879 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 05/23/2002 | US20020061872 For oral administration or embedded or otherwise attached to medical devices for blood collection and/or treatment |
| 05/23/2002 | US20020061860 Antisense oligonucleotide inhibition of specific histone deacetylase isoforms |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | US20020060304 Flourine-containing compound, and water and oil repellent composition |
| 05/22/2002 | EP1206447A1 Selective inhibitors of the urokinase plasminogene activators |
| 05/22/2002 | EP1206446A1 Carboxylic acid amides, their production and their use as drugs |
| 05/22/2002 | EP0681575B1 Process for the preparation of Baccatin III analogs bearing new C2 and C4 functional groups |
| 05/22/2002 | CN1350452A Preventive or therapeutic drugs for diabetes |
| 05/22/2002 | CN1349981A 2-naphtylamine-6-sulfonyl aniline and its prepn and application |
| 05/21/2002 | US6391918 N-sulphonyl and N-sulphinyl phenylglycinamide |
| 05/21/2002 | US6391904 Bone disorders |
| 05/21/2002 | US6391877 Eating disorders; sexual disorders; antidepressants; antiepileptic agents |
| 05/16/2002 | WO2002038850A2 Alkylated fluorochemical oligomers and use thereof in the treatment of fibrous substrates |
| 05/16/2002 | WO2001092217A3 Process for the preparation of amidostyrylstilbene-disulphonic acid compounds and novel amidostyrylstilbene-disulphonic acid compounds and their use as fluorescent whitening agents |
| 05/16/2002 | US20020058838 Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals |
| 05/16/2002 | US20020058710 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure |
| 05/16/2002 | US20020058654 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058195 High contrast, containing novel type of nucleating agent |
| 05/16/2002 | US20020056827 Piezoelectric element and process for production thereof |